Clinical Performance of Fiber Reinforced FRC Base and Bonded CAD/CAM Resin Composite Endocrowns

Not Applicable

Completed

• Conditions: Dental Caries
• Interventions: Procedure: Fiber flowable (SFRC) support below hybrid nanoceramic endocrowns; Procedure: all ceramic Endocrowns (emax)

• Registration Number: NCT06348979
• Lead Sponsor: Cairo University

Brief Summary

This research proposal is introduced to clinically test short fiber reinforced flowable resin composite material (everX Flow, GC Europe) as a supporting base under CAD/CAM resin composite endocrowns due to gap of knowledge present in this area.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-01
• Study First Submitted: 2023-12-07
• Primary Completion: 2023-12-30
• Study Completion: 2024-01-30
• Status Verified: 2024-03
• Study First Submitted QC: 2024-04-04
• Last Update Submitted: 2024-04-04
• Study First Posted: 2024-04-05
• Last Update Posted: 2024-04-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Endodontically treated molar teeth indicated for endocrown.
• Presence of favorable occlusion and teeth are in normal alignment with the adjacent teeth, -medically free

Read More

Exclusion Criteria

• ▪ Endodontically treated molar teeth indicated for post and core or only crown coverage.

  • Severe periodontal problems

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Hybrid Nano-ceramic (Grandio) CAD/CAM Endocrowns	Fiber flowable (SFRC) support below hybrid nanoceramic endocrowns	Adding of short fiber reinforced flowable resin composite material (everX Flow, GC Europe) as a supporting base under CAD/CAM resin composite endocrowns
Lithium Disilicate (e.max) Endocrowns	all ceramic Endocrowns (emax)	Lithium Disilicate (e.max) Endocrowns

Primary Outcome Measures

Name	Time	Method
clinical Fracture	change from baseline and months: 3, 6, 12	modified usphs criteria (alpha, bravo, charlie) with measuring unit: scoring system (ordinal)

Secondary Outcome Measures

Name	Time	Method
clinical performance marginal adaptation	change from baseline and months: 3, 6, 12	modified usphs criteria (alpha, bravo, charlie) with measuring unit:scoring system (ordinal)

Trial Locations

Locations (1)

Cairo University; 🇪🇬 Cairo, Egypt